Nicholas P. Restifo

96.1k citations
347 papers · 65.0k indexed · 36 hit papers · h-index 129
Topics
Immunotherapy and Immune Responses (239 papers)CAR-T cell therapy research (156 papers)Immune Cell Function and Interaction (140 papers)

In The Last Decade

Nicholas P. Restifo

344 papers receiving 63.8k citations

Hit Papers

Cancer immunotherapy: moving beyond current vaccines19932026200420152004200220062015201150010001.5k2.0k

Peers

Nicholas P. Restifo
Comparison fields: 5 of 165
  • Immunology 45.9k
  • Oncology 39.1k
  • Molecular Biology 17.7k
  • Genetics 9.7k
  • Biomedical Engineering 5.0k
Replace Drew M. Pardoll with:
Drew M. Pardoll United States
James P. Allison United States
Lloyd J. Old United States
Carl H. June United States
Arlene H. Sharpe United States
Mark J. Smyth Australia
Robert D. Schreiber United States
Gordon J. Freeman United States
Laurence Zitvogel France
Suzanne L. Topalian United States
Nicholas P. Restifo relative to Drew M. Pardoll United States Drew M. Pardoll's profile →
Citations per field
00.5×1.6×
Drew M. Pardoll · 1×
Citations per year

Countries citing papers authored by Nicholas P. Restifo

Since Specialization
Citations

This map shows the geographic impact of Nicholas P. Restifo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas P. Restifo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas P. Restifo more than expected).

Fields of papers citing papers by Nicholas P. Restifo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas P. Restifo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas P. Restifo. The network helps show where Nicholas P. Restifo may publish in the future.

Co-authorship network of co-authors of Nicholas P. Restifo

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas P. Restifo. A scholar is included among the top collaborators of Nicholas P. Restifo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas P. Restifo. Nicholas P. Restifo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 65
2 175
3
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cellsbreakdown →
506
4 139
5 332
6 178
7 90
8 234
9
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapybreakdown →
1603
10 225
11 343
12 245
13 207
14
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsbreakdown →
635
15
Tumor-specific Th17-polarized cells eradicate large established melanomabreakdown →
638
16
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimensbreakdown →
1017
17 358
18
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown →
1961
19
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and functionbreakdown →
592
20
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomabreakdown →
1234

About Nicholas P. Restifo

Nicholas P. Restifo is a scholar working on Immunology, Oncology and Genetics, having authored 347 papers that have together received 65.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (239 papers), CAR-T cell therapy research (156 papers) and Immune Cell Function and Interaction (140 papers). The work is most often cited by research in Immunology (45.9k citations), Oncology (39.1k citations) and Genetics (9.7k citations). Nicholas P. Restifo has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Steven A. Rosenberg, Luca Gattinoni, Mark E. Dudley, James C. Yang, Zhiya Yu, Christopher A. Klebanoff, Douglas C. Palmer, Richard M. Sherry, Pawel Muranski and James Chih‐Hsin Yang. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026